Internet+pharmaceutical supervision stricter industry standardized development accelerates

As of the closing of June 22, the Hong Kong stock market medical concept stock JD health and Ali's health have fallen by 14.83%and 13.84%, respectively.

The industry believes that the main reason for the adjustment of the above -mentioned industry's leading stock price is that the State Drug Administration recently issued the "Implementation Regulations of the People's Republic of China of the People's Republic of China (Revised Draft for Revised Draft)" (hereinafter referred to as the "Draft for Soliciting Opinions)) It is proposed that third -party platform providers shall not directly participate in pharmaceutical network sales activities.

In this regard, many Internet medical track companies are cautious. "We are also following the interpretation of this policy, and it is still evaluating its influence." A pharmaceutical e -commerce company who did not want to be named told the Securities Daily reporter.

"Under normal circumstances, since it has been included in the draft of comments, the possibility of landing is very high. But the market also depends on the scale of the policy after the policy is landed." The reporter said.

Third -party platform supervision is tight

The above -mentioned "Draft for Soliciting Opinions" clarifies the "third -party platform management obligations", and specifically includes: third -party platform providers of the drug network transaction shall be filed with the pharmaceutical supervision and management department of the people's government in the province, autonomous region, and municipality directly under the Central Government. Sales related services; third -party platform providers shall establish a drug network sales quality management system, set up special institutions, and equipped with related professionals such as pharmacy and technicians to establish and implement systems for drug quality management and distribution management. Third -party platform providers shall not directly participate in pharmaceutical network sales activities.

The "Draft for Soliciting Opinions" is also clear that the provider of third -party platforms should review the qualifications of the drug listing license holder and drug business enterprise, check the pharmaceutical information released, manage the transaction behavior, and save the drug display and preserve the display of drugs and the display of drugs and the display of drugs and the display of drugs and the display of drugs. Transaction management information.

It is worth mentioning that the "third -party platform provider must not directly participate in pharmaceutical network sales activities" in the "Draft for Soliciting Opinions" has attracted much attention from the market, which is directly related to the "drug" business of many pharmaceutical e -commerce platforms. But at present, the industry has different views on whether the requirements can be implemented, how to land, and whether it will be adjusted.

A medical e -commerce company who did not want to be named told the Securities Daily that the State Drug Administration may re -discuss and adjust some terms after receiving the opinions of all sectors of society on the "Draft for Soliciting Opinions". From a practical point of view, "platform+self -employment" is a common business model that is common in various industries; in addition, most platforms and self -employment are not a legal subject. "The above requirements only clarify the platform and the platform and the platform and the platform and the platform and the platform and the platform. The boundaries of self -employed will not have a significant impact on the pharmaceutical e -commerce business. "

"The third -party platform does not directly sell drugs, which means that the platform itself cannot sell drugs as business entities. At present, many platforms are sold to sell drugs through self -operated pharmacies. The two are different subjects." The senior management of the pharmaceutical retail industry company said, "This may depend on whether the relevant departments will take penetrating supervision. If it is not performed by penetrating supervision, it will have a little impact on the 'platform+self -employment' model."

The upstream prescription supervision is also stricter

Nowadays, the Internet medical industry is in the fast track of development, but there are still many chaos. According to reports, some Internet medical platforms "due to medicine formulas" and even "automatically generated prescriptions with artificial intelligence software" have repeatedly questioned public opinion.

In fact, not only the "Internet+Drug Sales" supervision has become stricter. Prior to this, it was also regulated by its upstream- "Internet+diagnosis and treatment".

Earlier, in order to regulate Internet diagnosis and treatment activities, strengthen the construction of the Internet diagnosis and treatment supervision system, and prevent the safety risks of Internet diagnosis and treatment, the General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine officially released the "Internet Diagnosis and Treatment Regulatory Detailed Rules (Trial)" (hereinafter referred to as "" "Details").

The "Detailed Rules" stipulates that the prescription should be prescribed by the doctor's itself, and it is strictly forbidden to use automatic prescriptions such as artificial intelligence. The prescription drug should be sold, adjusted and used by the doctor's prescription. It is strictly forbidden to provide medicines to patients before prescription. The rules also stipulate that the doctor must conduct real -name authentication before receiving the consultation to ensure that he provides diagnosis and treatment services. Other personnel, artificial intelligence software, etc. must not be used and replace the doctor's own diagnosis and treatment services. Health and health authorities at all levels shall be responsible for supervising personnel who conduct Internet diagnosis and treatment in the medical institution.

"The sales of prescription drugs include two important links, one is that the doctor prescribes a reasonable prescription; the other is to complete the medicine equipment and sales." Selling medicines can easily lead to excessive marketing. Drug sales and prescriptions are reasonably under the jurisdiction of different departments. The National Health and Health Commission issues the above rules to regulate the rationality of the prescription and whether it is in line with clinical guidelines and clinical use paths.

In this regard, the relevant person in charge of the Medical Federation told reporters that the introduction of the "Details" opened a new chapter in the Internet medical industry, and further clarified the goal of the healthy development of the Internet for the healthy development of the Internet. Support, conduct standardized supervision on medical institutions, personnel, service quality and safety. The "Details" marks the essential positioning of Internet diagnosis to return to "serious medical care".

(Editor in charge: Wang Qingyu)

- END -